0001415889-24-004400.txt : 20240220
0001415889-24-004400.hdr.sgml : 20240220
20240220165711
ACCESSION NUMBER: 0001415889-24-004400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furlong Tammy
CENTRAL INDEX KEY: 0001984204
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 24654490
MAIL ADDRESS:
STREET 1: C/O ELEVATION ONCOLOGY, INC.
STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 FEDERAL STREET
STREET 2: SUITE 1900
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7163711125
MAIL ADDRESS:
STREET 1: 101 FEDERAL STREET
STREET 2: SUITE 1900
CITY: BOSTON
STATE: MA
ZIP: 02110
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
form4-02202024_090251.xml
X0508
4
2024-02-15
0001783032
Elevation Oncology, Inc.
ELEV
0001984204
Furlong Tammy
C/O ELEVATION ONCOLOGY, INC.
101 FEDERAL STREET, SUITE 1900
BOSTON
MA
02110
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Common Stock
2024-02-15
4
M
0
1200
A
1200
D
Common Stock
2024-02-15
4
F
0
403
2.77
D
797
D
Stock Option (Right to Buy)
2.77
2024-02-15
4
A
0
225000
0
A
2034-02-14
Common Stock
225000
225000
D
Restricted Stock Unit
2024-02-15
4
A
0
37500
0
A
Common Stock
37500
37500
D
Restricted Stock Unit
2024-02-15
4
M
0
1200
0
D
Common Stock
1200
3600
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
The stock option vests as to 25% of the total shares on February 15, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
25% of the RSUs vest on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
The RSUs do not expire; they either vest or are canceled prior to the vesting date.
25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
/s/ Robert Yang, Attorney-in-Fact
2024-02-20